Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
93954933 | 9395493 | 3 | F | 20160908 | 20130711 | 20160915 | EXP | CN-ASTELLAS-2013US007092 | ASTELLAS | WU S, LUO H, WANG L, ZHANG X, XIA B, XIE C, ET AL. PHASE III RANDOMIZED STUDY OF ELECTIVE NODAL IRRADIATION PLUS ERLOTINIB COMBINED WITH CHEMOTHERAPY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ABSTRACT NO. 4048).. JOURNAL OF CLINICAL ONCOLOGY. 2016;34(SUPP15):NO INFORMATION | 58.00 | YR | M | Y | 0.00000 | 20160915 | CN | GB | CN |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
93954933 | 9395493 | 1 | PS | Erlotinib | ERLOTINIB | 1 | Oral | 21743 | 150 | MG | TABLET | QD | |||||||
93954933 | 9395493 | 2 | SS | CISPLATIN. | CISPLATIN | 1 | Intravenous (not otherwise specified) | 20 MG/M2, DAY 1-3, EVERY 4 WEEKS FOR 2 CYCLES | 0 | 20 | MG/M**2 | FORMULATION UNKNOWN | |||||||
93954933 | 9395493 | 3 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | 135 MG/M2, DAY 1 EVERY 4 WEEKS FOR TWO CYCLES | 0 | 135 | MG/M**2 | FORMULATION UNKNOWN |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
93954933 | 9395493 | 1 | Oesophageal squamous cell carcinoma |
93954933 | 9395493 | 2 | Oesophageal squamous cell carcinoma |
93954933 | 9395493 | 3 | Oesophageal squamous cell carcinoma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
93954933 | 9395493 | DE |
93954933 | 9395493 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
93954933 | 9395493 | Gastrointestinal toxicity | |
93954933 | 9395493 | Haematotoxicity |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |